Skip to main navigation Skip to search Skip to main content

I-123 metaiodobenzylguanidine myocardial scintigraphy in a patient with Brugada syndrome

  • Teikyo University

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The Brugada syndrome has characteristic electrocardiographic (ECG) findings: a right bundle branch block (RBBB) pattern with normal Q-T interval and S-T elevation in V1, V2, and V3. The ECG findings are unrelated to a serum electrolyte abnormality, structural heart disease, or ischemia. Patients with this syndrome have an increased incidence of syncope attacks and a greater possibility of sudden death. I-123 metaiodobenzylguanidine (MIBG) myocardial scintigraphy in a patient with the Brugada syndrome showed decreased I-123 MIBG uptake in the left ventricular myocardium. This finding suggested a local sympathetic nerve abnormality in the left ventricular myocardium, as indicated in previous reports.

Original languageEnglish
Pages (from-to)1058-1059
Number of pages2
JournalClinical Nuclear Medicine
Volume26
Issue number12
DOIs
StatePublished - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Brugada syndrome
  • I-123 metaiodobenzylguanidine scintigraphy
  • Sympathetic nerve

Fingerprint

Dive into the research topics of 'I-123 metaiodobenzylguanidine myocardial scintigraphy in a patient with Brugada syndrome'. Together they form a unique fingerprint.

Cite this